N.J. Admin. Code § 13:35-2A.23

Current through Register Vol. 56, No. 24, December 18, 2024

Section 13:35-2A.23 - Telemedicine: prescriptions

(a) Notwithstanding requirements for in-person interaction in N.J.A.C. 13:35-7, a certified nurse midwife (CNM) with prescriptive authority pursuant to N.J.A.C. 13:35-2A.14providing services through telemedicine or telehealth may issue a prescription to a patient, as long as the issuance of such a prescription is consistent with the standard of care or practice standards applicable to the in-person setting.

(b) A CNM with prescriptive authority pursuant to N.J.A.C. 13:35-2A.14shall not issue a prescription based solely on responses provided in an online questionnaire, unless the CNM has established a proper licensee-patient relationship pursuant to N.J.A.C. 13:35-2A.21.

(c) Notwithstanding (a) above, and except as provided in (d) below, a CNM with prescriptive authority pursuant to N.J.A.C. 13:35-2A.14shall not issue a prescription for a Schedule II controlled dangerous substance unless the CNM has had an initial in-person examination of the patient and a subsequent in-person visit with the patient at least every three months for the duration of the time the patient is prescribed the Schedule II controlled dangerous substance.

(d) The prohibition of (c) above shall not apply when a CNM with prescriptive authority pursuant to N.J.A.C. 13:35-2A.14prescribes a stimulant for a patient under the age of 18 years, as long as the CNM is using interactive, real-time, two-way audio and video technologies and the CNM has obtained written consent for a waiver of in-person examination requirements from the patient's parent or guardian.

N.J. Admin. Code § 13:35-2A.23

Adopted by 52 N.J.R. 894(a), effective 4/20/2020